TY - JOUR
T1 - Management of Hemarthrosis
AU - Green, D.
AU - Schmid, F. R.
PY - 1970/5/21
Y1 - 1970/5/21
N2 - To the Editor: Kisker and Burke (N.E.J.M. 282:639–642, 1970) advocate the use of oral corticosteroids on a short-term basis in the treatment of the hemarthrosis of hemophilia. We are concerned about two aspects of their study. The first is the fact that they based their decision on the amount of blood-fraction replacement therapy required by the patient on their clinical evaluation of the affected joint. Decrease in pain and increase in motion in the patients treated with corticosteroids was equated with reduction of bleeding into the joint, an assumption that requires proof. In our experience, particularly with recurrent hemarthrosis, small.
AB - To the Editor: Kisker and Burke (N.E.J.M. 282:639–642, 1970) advocate the use of oral corticosteroids on a short-term basis in the treatment of the hemarthrosis of hemophilia. We are concerned about two aspects of their study. The first is the fact that they based their decision on the amount of blood-fraction replacement therapy required by the patient on their clinical evaluation of the affected joint. Decrease in pain and increase in motion in the patients treated with corticosteroids was equated with reduction of bleeding into the joint, an assumption that requires proof. In our experience, particularly with recurrent hemarthrosis, small.
UR - http://www.scopus.com/inward/record.url?scp=0014957599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0014957599&partnerID=8YFLogxK
U2 - 10.1056/NEJM197005212822123
DO - 10.1056/NEJM197005212822123
M3 - Letter
C2 - 5440065
AN - SCOPUS:0014957599
SN - 0028-4793
VL - 282
SP - 1212
EP - 1213
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 21
ER -